P Kissel, P Tridon, J M André. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Blood-Brain Barrier/drug effectsDihydroxyphenylalanine/administration & dosageDihydroxyphenylalanine/pharmacologyDihydroxyphenylalanine/therapeutic useDrug SynergismDrug Therapy, CombinationHumansNeurotransmitter AgentsParkinson Disease/complicationsParkinson Disease/drug therapyPropranolol/administration & dosagePropranolol/pharmacologyPropranolol/therapeutic useTremor/drug therapyTremor/etiology
Substances: See more » Neurotransmitter AgentsDihydroxyphenylalaninePropranolol
Year: 1974 PMID: 4131047 DOI: 10.1016/s0140-6736(74)93165-1
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321